Vaneck Pharmaceutical Etf Price Patterns
| PPH Etf | USD 105.65 0.26 0.25% |
Momentum 70
Buy Stretched
Oversold | Overbought |
Using VanEck Pharmaceutical hype-based prediction, you can estimate the value of VanEck Pharmaceutical ETF from the perspective of VanEck Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in VanEck Pharmaceutical to buy its etf at a price that has no basis in reality. In that case, they are not buying VanEck because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
VanEck Pharmaceutical after-hype prediction price | USD 105.65 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out VanEck Pharmaceutical Basic Forecasting Models to cross-verify your projections. VanEck Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of VanEck Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VanEck Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of VanEck Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
VanEck Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting VanEck Pharmaceutical's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VanEck Pharmaceutical's historical news coverage. VanEck Pharmaceutical's after-hype downside and upside margins for the prediction period are 104.68 and 106.62, respectively. We have considered VanEck Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
VanEck Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of VanEck Pharmaceutical ETF is based on 3 months time horizon.
VanEck Pharmaceutical Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as VanEck Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VanEck Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VanEck Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 0.97 | 0.00 | 3.70 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
105.65 | 105.65 | 0.00 |
|
VanEck Pharmaceutical Hype Timeline
On the 29th of January VanEck Pharmaceutical ETF is traded for 105.65. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -3.7. VanEck is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.23%. %. The volatility of related hype on VanEck Pharmaceutical is about 6.03%, with the expected price after the next announcement by competition of 101.95. Considering the 90-day investment horizon the next projected press release will be within a week. Check out VanEck Pharmaceutical Basic Forecasting Models to cross-verify your projections.VanEck Pharmaceutical Related Hype Analysis
Having access to credible news sources related to VanEck Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict VanEck Pharmaceutical's future price movements. Getting to know how VanEck Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VanEck Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SGDM | Sprott Gold Miners | 0.00 | 0 per month | 1.69 | 0.27 | 4.65 | (3.85) | 11.03 | |
| CXSE | WisdomTree China ex State Owned | 0.00 | 0 per month | 1.04 | (0.05) | 1.61 | (1.65) | 5.35 | |
| BKMC | BNY Mellon Mid | 0.00 | 0 per month | 0.76 | 0.06 | 1.61 | (1.33) | 3.69 | |
| VNM | VanEck Vietnam ETF | 0.00 | 0 per month | 1.46 | 0.05 | 2.77 | (2.49) | 7.77 | |
| NUKZ | Exchange Traded Concepts | 0.00 | 0 per month | 1.81 | (0.04) | 2.51 | (3.25) | 5.80 | |
| IHE | iShares Pharmaceuticals ETF | 0.00 | 0 per month | 0.52 | 0.17 | 1.82 | (1.16) | 4.45 | |
| EBI | Longview Advantage ETF | 0.00 | 0 per month | 0.62 | 0.08 | 1.40 | (1.35) | 3.43 | |
| BBH | VanEck Biotech ETF | (160.86) | 1 per month | 0.73 | 0.11 | 2.46 | (1.31) | 5.66 | |
| OSEA | Harbor ETF Trust | 0.00 | 0 per month | 0.82 | (0.03) | 1.09 | (1.35) | 3.57 | |
| FYC | First Trust Small | 0.00 | 0 per month | 1.22 | 0.04 | 2.04 | (2.10) | 5.20 |
VanEck Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine VanEck price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VanEck using various technical indicators. When you analyze VanEck charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About VanEck Pharmaceutical Predictive Indicators
The successful prediction of VanEck Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as VanEck Pharmaceutical ETF, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of VanEck Pharmaceutical based on analysis of VanEck Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to VanEck Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VanEck Pharmaceutical's related companies.
Currently Active Assets on Macroaxis
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:Check out VanEck Pharmaceutical Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between VanEck Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding VanEck Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, VanEck Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.